markets

5/29/25

Morgan Stanley on Nvidia: “Everything should get better from here”

Was that... the bad part? Because after the insane profit growth that’s seen Nvidia beat earnings expectations for 10 consecutive quarters, becoming a $3 trillion company in the process, Morgan Stanley analysts think “everything should get better from here.”

The chip designer’s Q1 results and Q2 guidance underscored that any issues with the AI boom are not related to demand. The sticking points for Nvidia are how much and how fast the company can roll out new products that everyone wants, and who’s allowed to buy them.

“Nvidia is outgrowing expectations despite supply constraints, and is outgrowing competition by a larger magnitude,” wrote a team led by Joseph Moore, who affirmed the company as his top pick in the semi industry and cited improving rack supply, a massive backlog, and the potential for some bounce-back in its China business as positive news for the company going forward.

Nvidia spelled out that revenues would have been $2.5 billion higher if not for the H20 export ban that prevented sales to China from April 9 on. Despite that, and the $8 billion in sales it expects to forgo in the current quarter, its Q2 revenue forecast was virtually in line with estimates that many analysts thought were too high and hadn’t adequately factored in China-linked headwinds.

“Without H20 ban, the company would have beaten guidance by over $3 billion for April,” Moore wrote. “We do believe that at current revenue levels there is significant unmet demand, so ongoing supply constraints could keep things better for longer.”

Moore boosted his price target on the stock to $170 from $160 and raised revenues and earnings estimates for both this year and the next.

More Markets

See all Markets

markets

12m

Rocket lab soars to new record close amid rally for retail faves

Rocket Lab ripped by roughly 10% Friday to close at a new all-time high, riding an upturn of retail enthusiasm for a coterie of tech-themed favorites, even as the broader market was more or less flat on the day.

Goldman Sachs’ basket of “retail favorites” — its heaviest weights are Reddit, AppLovin, and Tempus AI — was the second-biggest gainer among the company’s flagship US equity baskets on Friday, rising about 1.6%. The S&P was almost dead flat.

It’s not Rocket Lab’s first retail rodeo, as the money-losing company has more than doubled this year and is up nearly 700% over the last 12 months.

Oracle Wall Street Revisions

Analysts revise up anything and everything they thought about Oracle

After the company’s bombshell earnings this week, Wall Street thinks Oracle’s trajectory has changed.

Matt Phillips2h

markets

3h

Six Flags pops after reiterating its guidance as theme park attendance rebounds

Six Flags shares rose more than 7% today after the company reported a rebound in attendance and early season pass sales heading into the fall. The nine-week period ended August 31 saw 17.8 million guests, up about 2% from the same stretch last year, with stronger momentum in the final four weeks.

More importantly, Six Flags reaffirmed its full-year adjusted EBITDA guidance of $860 million to $910 million, showing confidence that its cost and operations strategy can stay strong for the duration of the year. Riding that wave, Six Flags also said early 2026 season pass unit sales are pacing ahead of last year, and average season pass prices are up about 3%.

The good vibes come despite a drop in in-park per-capita spending, especially from admissions, where promotions and changes to attendance mix (which parks or days guests visit) have weighed. Earlier this week, the amusement giant signed a new agreement that extended its position as the exclusive amusement park partner for Peanuts™ in North America through 2030.

Despite the rally, Six Flags shares are down about 52% year to date.

markets

4h

Rivian turns red on the year, squeezed by a recall and the looming end of the EV tax credit

Shares of EV maker Rivian are down more than 5% on Friday following the company’s recall of 24,214 vehicles due to a software issue. The stock move erases Rivian’s year-to-date gain and turns the company negative on the year.

Rivian’s 2025 model year R1S and R1T are affected by the defect, which was identified after a vehicle’s hands-free highway assist software failed to identify another vehicle on the road, causing a low-speed collision. Rivian said it’s released an over-the-air update to fix the issue.

The recall marks Rivian’s fifth this year, affecting nearly 70,000 of its vehicles.

Rivian’s shares are down more than 20% from their 2025 high, which came prior to the passage of President Trump’s “big, beautiful bill.” Through the legislation, the $7,500 EV tax credit is set to expire at the end of the month.

markets

J. Edward Moreno

5h

Moderna, Pfizer dip after WaPo reports Trump officials’ plan to link Covid vaccines to child deaths

Vaccine makers are falling after The Washington Post reported that the Trump administration plans to link the coronavirus vaccine to 25 child deaths.

Moderna and Pfizer, the two companies who sell the vaccine in the US, fell by more than 5% and 2%, respectively. The coronavirus vaccine is virtually the only revenue driver for Moderna, while Pfizer has a larger and more diverse portfolio.

Trump officials to link child deaths to covid shots, alarming career scientists

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.

©2025 Sherwood Media, LLC